Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
11 hedge funds and large institutions have $4.63K invested in Coeptis Therapeutics Warrants in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
69% less capital invested
Capital invested by funds: $14.9K → $4.63K (-$10.3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$403 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$63 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$3.02K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
-$2.04K |
| 3 |
CS
Clear Street
New York
|
-$2 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1 |
COEPW Hedge Fund Activity: Q4 2025 in Review
11 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2025, worth a combined $4.63K — down 69% from $14.9K a quarter earlier.
Fund positioning in COEPW was balanced in Q4 2025: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $403. The largest seller was Meteora Capital, exiting entirely with an estimated $3.02K sold.
- 11 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $4.63K of Coeptis Therapeutics Warrants stock for Q4 2025, down 69% quarter-over-quarter.
- 2 funds opened new Coeptis Therapeutics Warrants positions in Q4 2025 and 2 closed out, a net change of 0 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q4 2025 was Virtu Financial, an estimated $403 added.
- The largest Coeptis Therapeutics Warrants seller in Q4 2025 was Meteora Capital, an estimated $3.02K sold.
Based on aggregated 13F filings for Q4 2025.